TNGX Stock Analysis: Buy, Sell, or Hold?
TNGX - Tango Therapeutics, Inc.
$19.21
-0.05 (-0.26%)
โผ
5d:
+1.32%
30d:
+72.44%
90d:
+121.57%
BUY
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 11, 2026
Smart Money Accumulation
TNGX is down 10.7% this week, but smart money is accumulating calls. Top strike: $10 2026-05-15 with 208 OI. Call ratio: 82% View Scanner →
Strength: 8.6/10
Get Alerted When TNGX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
๐ก BUY OPPORTUNITY: TNGX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
๐ก BUY OPPORTUNITY: TNGX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: TNGX is currently trading at $19.21, which is considered slightly high relative to its 30-day fair value range of $12.90 to $19.28.
Technical Outlook: Technically, TNGX is in a strong uptrend. Immediate support is located at $17.52, while resistance sits at $21.82.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TNGX is in a strong uptrend. Immediate support is located at $17.52, while resistance sits at $21.82.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$12.90 -
$19.28
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.6%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($20.44)
Fair Price Analysis
30-Day Fair Range
$12.90 -
$19.28
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$17.52
Resistance Level
$21.82
Current Trend
Strong Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.55
Wall Street Target
$20.44
(+6.4%)
Revenue Growth (YoY)
-100.0%
Profit Margin
-162.8%
Share & Embed Analysis
Last updated: March 30, 2026 6:40 PM ET
Data refreshes hourly during market hours. Next update: 7:40 PM
Data refreshes hourly during market hours. Next update: 7:40 PM
๐ฅ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNGX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Adam Crystal
SELL
20251 shares
2026-03-05
Adam Crystal
SELL
54345 shares
2026-02-25
Adam Crystal
SELL
18452 shares
2026-02-03
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 61 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 54 HOLD |
|
NRIX
Nurix Therapeuticsย Inc |
STRONG BUY
18 analysts |
$30 | 56 HOLD |
Advanced TNGX Option Strategies
Professional options setups generated by AI based on today's TNGX price and gamma walls.